Michael Woudenberg
Fortune : 2 $ au 31/05/2026
Fortune : 2 $ au 31/05/2026
Michael Woudenberg is currently Chief Operating Officer at InMed Pharmaceuticals, Inc., a position held since 2022.
Formerly, Mr. Woudenberg was Managing Director at Phyton Biotech LLC.
Mr. Woudenberg completed undergraduate studies at the University of Western Ontario.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/12/2025 | 1 ( 0% ) | 2 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Directeur des opérations | 15/07/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Phyton Biotech LLC
Phyton Biotech LLC BiotechnologyHealth Technology Develops plant molecules | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phyton Biotech LLC
Phyton Biotech LLC BiotechnologyHealth Technology Develops plant molecules | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national